Found: 97
Select item for more details and to access through your institution.
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
- Published in:
- European Journal of Immunology, 2013, v. 43, n. 10, p. 2554, doi. 10.1002/eji.201343324
- By:
- Publication type:
- Article
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 11, p. 3114, doi. 10.1002/eji.201141836
- By:
- Publication type:
- Article
Influenza matrix 1-specific human CD4.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 11, p. 3064, doi. 10.1002/eji.200940177
- By:
- Publication type:
- Article
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8707, doi. 10.3390/ijms23158707
- By:
- Publication type:
- Article
Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 11, p. 1989, doi. 10.3390/jcm8111989
- By:
- Publication type:
- Article
Characterization of the early cellular immune response induced by HPV vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.863164
- By:
- Publication type:
- Article
Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.924099
- By:
- Publication type:
- Article
Identification of HLA-A*0201-restricted CTL epitopes encoded by the tumor-specific MAGE-2 gene product.
- Published in:
- International Journal of Cancer, 1997, v. 73, n. 1, p. 125, doi. 10.1002/(SICI)1097-0215(19970926)73:1<125::AID-IJC19>3.0.CO;2-F
- By:
- Publication type:
- Article
Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope.
- Published in:
- International Journal of Cancer, 1997, v. 72, n. 6, p. 1122, doi. 10.1002/(SICI)1097-0215(19970917)72:6<1122::AID-IJC30>3.0.CO;2-3
- By:
- Publication type:
- Article
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitope.
- Published in:
- International Journal of Cancer, 1997, v. 70, n. 3, p. 302, doi. 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H
- By:
- Publication type:
- Article
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma.
- Published in:
- Nature Medicine, 2015, v. 21, n. 1, p. 81, doi. 10.1038/nm.3773
- By:
- Publication type:
- Article
Interferon‐γ and IL‐5 associated cell‐mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosa.
- Published in:
- Clinical & Experimental Dental Research, 2021, v. 7, n. 5, p. 903, doi. 10.1002/cre2.396
- By:
- Publication type:
- Article
Features of effective T Cell-inducing vaccines against Chronic viral infections.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00276
- By:
- Publication type:
- Article
T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1<sup>b</sup> with TAP-Independent Peptides Are Semi-Invariant Lymphocytes.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00060
- By:
- Publication type:
- Article
SPONTANEOUSLY INDUCED CELLULAR IMMUNITY TO HPV-16/18 AND THE THERAPEUTIC VACCINATION OF PATIENTS WITH HPV-16/18 (PRE-)MALIGNANT LESIONS.
- Published in:
- Central European Journal of Public Health, 2008, v. 16, p. S16
- By:
- Publication type:
- Article
Perspectives from the leadership of Journal for ImmunoTherapy of Cancer.
- Published in:
- Journal of International Society of Preventive & Community Dentistry, 2024, v. 14, n. 3, p. 1, doi. 10.1136/jitc-2024-009661
- By:
- Publication type:
- Article
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0104230
- By:
- Publication type:
- Article
Human Papillomavirus Deregulates the Response of a Cellular Network Comprising of Chemotactic and Proinflammatory Genes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017848
- By:
- Publication type:
- Article
Evaluation of Immunological Cross-Reactivity between Clade A9 High-Risk Human Papillomavirus Types on the Basis of E6-Specific CD4+ Memory T Cell Responses.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 8, p. 1200, doi. 10.1086/656367
- By:
- Publication type:
- Article
p53: A Potential Target Antigen for Immunotherapy of Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 910, n. 1, p. 223, doi. 10.1111/j.1749-6632.2000.tb06711.x
- By:
- Publication type:
- Article
Monocyte infiltration is an independent positive prognostic biomarker in vulvar squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 9, p. 1, doi. 10.1007/s00262-024-03755-w
- By:
- Publication type:
- Article
The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1553, doi. 10.1007/s00262-022-03350-x
- By:
- Publication type:
- Article
Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 2, p. 289, doi. 10.1007/s00262-021-02984-7
- By:
- Publication type:
- Article
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 771, doi. 10.1007/s00262-020-02506-x
- By:
- Publication type:
- Article
Short-Term Fasting Synergizes with Solid Cancer Therapy by Boosting Antitumor Immunity.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1390, doi. 10.3390/cancers14061390
- By:
- Publication type:
- Article
Predictive Biomarkers for Outcomes of Immune Checkpoint Inhibitors (ICIs) in Melanoma: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6366, doi. 10.3390/cancers13246366
- By:
- Publication type:
- Article
PROTECT: Prospective Phase-II-Trial Evaluating Adaptive Proton Therapy for Cervical Cancer to Reduce the Impact on Morbidity and the Immune System.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5179, doi. 10.3390/cancers13205179
- By:
- Publication type:
- Article
Future Challenges in Cancer Resistance to Immunotherapy.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 935, doi. 10.3390/cancers12040935
- By:
- Publication type:
- Article
Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma.
- Published in:
- Cancers, 2019, v. 11, n. 8, p. 1102, doi. 10.3390/cancers11081102
- By:
- Publication type:
- Article
Uveal Versus Cutaneous Melanoma; Same Origin, Very Distinct Tumor Types.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 845, doi. 10.3390/cancers11060845
- By:
- Publication type:
- Article
Cryopreservation of MHC multimers: Recommendations for quality assurance in detection of antigen specific T cells.
- Published in:
- Cytometry. Part A, 2015, v. 87, n. 1, p. 37, doi. 10.1002/cyto.a.22575
- By:
- Publication type:
- Article
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines.
- Published in:
- ChemBioChem, 2021, v. 22, n. 7, p. 1215, doi. 10.1002/cbic.202000687
- By:
- Publication type:
- Article
Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes.
- Published in:
- Immunological Reviews, 2002, v. 188, n. 1, p. 177, doi. 10.1034/j.1600-065X.2002.18816.x
- By:
- Publication type:
- Article
Effect of hypoxic stress on migration and characteristics of monocytes in uveal melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Effect of Hypoxic Stress on Migration and Characteristics of Monocytes in Uveal Melanoma.
- Published in:
- JAMA Ophthalmology, 2014, v. 132, n. 5, p. 614, doi. 10.1001/jamaophthalmol.2014.43
- By:
- Publication type:
- Article
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.545385
- By:
- Publication type:
- Article
NKG2A is a late immune checkpoint on CD8 T cells and marks repeated stimulation and cell division.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 4, p. 688, doi. 10.1002/ijc.33859
- By:
- Publication type:
- Article
Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry Samples.
- Published in:
- PLoS Computational Biology, 2013, v. 9, n. 7, p. 1, doi. 10.1371/journal.pcbi.1003130
- By:
- Publication type:
- Article
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Therapeutic cancer vaccines.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3401, doi. 10.1172/JCI80009
- By:
- Publication type:
- Article
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 7, p. 509, doi. 10.1038/sj.cgt.7700600
- By:
- Publication type:
- Article
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance.
- Published in:
- Science Immunology, 2023, v. 8, n. 83, p. 1, doi. 10.1126/sciimmunol.abn6173
- By:
- Publication type:
- Article
Photochemical Internalization Enhanced Vaccination Is Safe, and Gives Promising Cellular Immune Responses to an HPV Peptide-Based Vaccine in a Phase I Clinical Study in Healthy Volunteers.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.576756
- By:
- Publication type:
- Article
Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 4, p. 838, doi. 10.1002/ijc.23570
- By:
- Publication type:
- Article
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 1, p. 146, doi. 10.1002/ijc.23502
- By:
- Publication type:
- Article
Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.
- Published in:
- International Journal of Cancer, 2008, v. 122, n. 3, p. 486, doi. 10.1002/ijc.23162
- By:
- Publication type:
- Article
Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 12, p. 2711, doi. 10.1002/ijc.23035
- By:
- Publication type:
- Article
Detection of human papillomavirus type 18 E6 and E7-specific CD4+ T-helper 1 immunity in relation to health versus disease.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 4, p. 950, doi. 10.1002/ijc.21459
- By:
- Publication type:
- Article
Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 3, p. 675, doi. 10.1002/ijc.21394
- By:
- Publication type:
- Article
Rapid enrichment of human papillomavirus (HPV)-specific polyclonal T cell populations for adoptive immunotherapy of cervical cancer.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 2, p. 274, doi. 10.1002/ijc.20721
- By:
- Publication type:
- Article